BioSpace News Archive

BioCapital

Bitar Cosmetic Surgery Institute Earns Esteemed ASAPS Endorsement for Fellowship Program

Drs. Bitar and Lickstein To Train and Mentor a Board Eligible Plastic Surgeon in Advanced Aesthetic Surgery

November 1, 2018
·
2 min read
Business

XTL Biopharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Update

TL Biopharmaceuticals Ltd. announced financial results for the quarter ended September 30, 2018 and provided an update on the development program for its lead drug candidate hCDR1.

November 1, 2018
·
6 min read
Business

U.S. Department of State Medical Informatics Expert Dean Smith, MD, Joins GlobalMed as CMIO

Dean L. Smith, MD, MBI, joins GlobalMed as Chief Medical Information Officer and Senior Vice President of Government Relations, effective Nov. 1.

November 1, 2018
·
4 min read
Policy

Parent Project Muscular Dystrophy Designates Children’s National Health System, a Certified Duchenne Care Center

Clinic Receives Distinction from Leading Duchenne Organization in Recognition of Ongoing Effort to Ensure People with Duchenne Receive Optimal Care

November 1, 2018
·
5 min read
Policy

Ascendant New York Detox Facility Achieves Behavioral Health Care Accreditation From The Joint Commission

Ascendant New York today announced it has earned The Joint Commission’s Gold Seal of Approval® for Behavioral Health Care Accreditation by demonstrating continuous compliance with its performance standards.

November 1, 2018
·
3 min read
Job Trends

Biomarker blood test accurately confirms remission in patients with HPV-associated oral cancer

Sophisticated liquid biopsy test could reduce the need for radiological studies such as PET/CT scans during post-radiation therapy surveillance

November 1, 2018
·
7 min read
Pharm Country

Janssen Shows Commitment to Advancing the Science and Treatment of Blood Cancers and Related Conditions With More Than 80 ASH 2018 Data Presentations From Differentiated Oncology and Cardiovascular Portfolios

IMBRUVICA® - Additional data supporting IMBRUVICA in newly diagnosed CLL, including Phase 3 results of IMBRUVICA plus obinutuzumab, and up to 7-year follow-up monotherapy data

November 1, 2018
·
43 min read
BioForest

LUNGevity Spreads Awareness and Education through November

New Lung Cancer Awareness Month activities launched for advocates

November 1, 2018
·
3 min read
Policy

Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health and Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research

Genetic testing can provide helpful information about how an individual’s genes may predispose them to certain diseases and conditions, which may prompt consumers to be more engaged in pursuing the benefits of healthy lifestyle choices and more aware of their health risks.

November 1, 2018
·
5 min read
Drug Development

Alexion Announces Upcoming Data Presentations at American Society of Hematology Annual Meeting

Nine abstracts accepted, including three oral presentations of ALXN1210 Phase 3 PNH data

November 1, 2018
·
15 min read